Company intelligence / Profile preview
Bio-Phoenix
Taipei, Taiwanbio-phoenix.com ↗
- Ownership
- Public · 4755
- Employees
- ~30
- Development stage
- Other
01
Overview
Bio-Phoenix is a biotechnology company specializing in the development of exosome-based therapies and regenerative medicine. The company utilizes its proprietary Phoenix-I platform for high-purity, industrial-scale exosome isolation from mesenchymal stem cells (MSCs) and immune cells, targeting indications in dermatology, pulmonology, and oncology.
- Therapeutic areas
- OncologyPulmonologyDermatology
- Modalities
- Exosome-based therapyCell therapyStem cell therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Bio-Phoenix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-Phoenix.